UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 21, 2015
REPRO MED SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
New York | 0-12305 | 13-3044880 |
(State or other jurisdiction | (Commission | (IRS Employer |
24 Carpenter Road, Chester, New York | 10918 |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code (845) 469-2042
not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.
Appointment of Director
On October 21, 2015, Cyril Nicholas Narishkin was appointed as an additional member of the Board of Directors of Repro Med Systems, Inc. Mr. Narishkin started his career in management at Texas Instruments (1986 - 1997). He then held successful senior corporate executive positions with Supply Velocity (1997 - 2001 & 2008 to current), Paric Corporation (2008 - 2009), and Essex Industries (2001 - 2008). He has been an Adjunct Professor at Washington University in St. Louis’ Olin Business School, and at Saint Louis University’s Cook School of Business. Mr. Narishkin received a BS in Mechanical Engineering from Tufts University (Magna cum Laude) and an Executive Masters in Business Administration from Olin Business School, Washington University in St. Louis.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| REPRO MED SYSTEMS, INC. | |
|
|
|
Date: October 23, 2015 | By: | /s/ Andrew I. Sealfon |
| Andrew I. Sealfon | |
- 2 -